Cipla Ltd.
BSE: 500087 | NSE: CIPLA
Large Cap | Pharmaceuticals & Drugs
1426.80
-11.95 (-0.83%) Cipla - Quaterly Results
Date: 27-10-2023
The company witnessed a 12.37% growth in the revenue at Rs. 46647.20 millions for the quarter ended September 2023 as compared to Rs. 41512.70 millions during the year-ago period.Net Profit recorded in the quarter ended September 2023 rise to 46.02% to Rs. 10296.90 millions compared to R. 7051.90 millions in corresponding previous quarter.Operating profit for the quarter ended September 2023 rose to 15842.10 millions as compared to 11533.30 millions of corresponding quarter ended September 2022.
(Rs. in Million) |
| Quarter ended | Year to Date | Year ended | |||||||
| 202309 | 202209 | % Var | 202309 | 202209 | % Var | 202303 | 202203 | % Var | |
| Sales | 46647.20 | 41512.70 | 12.37 | 89829.10 | 79974.10 | 12.32 | 157906.00 | 153808.20 | 2.66 |
| Other Income | 2050.90 | 922.80 | 122.25 | 3630.70 | 2099.60 | 72.92 | 4567.90 | 6667.00 | -31.48 |
| PBIDT | 15842.10 | 11533.30 | 37.36 | 29468.80 | 22646.50 | 30.13 | 42493.70 | 43779.30 | -2.94 |
| Interest | 78.00 | 75.00 | 4.00 | 81.10 | 97.10 | -16.48 | 270.20 | 269.30 | 0.33 |
| PBDT | 15764.10 | 11458.30 | 37.58 | 29387.70 | 22549.40 | 30.33 | 40364.50 | 43510.00 | -7.23 |
| Depreciation | 1798.10 | 1760.10 | 2.16 | 3157.60 | 3043.70 | 3.74 | 5959.10 | 5466.20 | 9.02 |
| PBT | 13966.00 | 9698.20 | 44.01 | 26230.10 | 19505.70 | 34.47 | 34405.40 | 38043.80 | -9.56 |
| TAX | 3669.10 | 2646.30 | 38.65 | 6983.00 | 5150.50 | 35.58 | 9710.10 | 9218.00 | 5.34 |
| Deferred Tax | -13.00 | -6.00 | 116.67 | -102.50 | -95.30 | 7.56 | -400.90 | -276.90 | 44.78 |
| PAT | 10296.90 | 7051.90 | 46.02 | 19247.10 | 14355.20 | 34.08 | 24695.30 | 28825.80 | -14.33 |
| Equity | 1614.70 | 1614.00 | 0.04 | 1614.70 | 1614.00 | 0.04 | 1614.30 | 1613.60 | 0.04 |
| PBIDTM(%) | 33.96 | 27.78 | 22.24 | 32.81 | 28.32 | 15.85 | 26.91 | 28.46 | -5.46 |